Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Cyclically Adjusted Book per Share: ¥ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603456 Zhejiang Jiuzhou Pharmaceutical Co Ltd SHSE:603456
98 GF Score
Price ¥15.52
GF Value ¥16.84
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Book per Share?

Zhejiang Jiuzhou Pharmaceutical Co SHSE:603456 +0.26% 98 Cyclically Adjusted Book per Share is ¥ as of Jun. 2026. GuruFocus rates SHSE:603456 with a GF Score™ of 98/100 and a GF Value™ of ¥16.84 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Zhejiang Jiuzhou Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was ¥10.263. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥ for the trailing ten years ended in Jun. 2026.

During the past 12 months, Zhejiang Jiuzhou Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 13.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 16.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Zhejiang Jiuzhou Pharmaceutical Co was 16.70% per year. The lowest was 16.70% per year. And the median was 16.70% per year.

As of today (2026-09-20), Zhejiang Jiuzhou Pharmaceutical Co's current stock price is ¥15.52. Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ¥. Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Jiuzhou Pharmaceutical Co was 16.41. The lowest was 2.05. And the median was 3.43.


Zhejiang Jiuzhou Pharmaceutical Co  (SHSE:603456) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Jiuzhou Pharmaceutical Co was 16.41. The lowest was 2.05. And the median was 3.43.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SHSE:603456 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:603456
98GF Score
Zhejiang Jiuzhou Pharmaceutical Co Ltd SHSE:603456
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Jiuzhou Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=10.263/116.0564*116.0564
=10.263

Current CPI (Jun. 2026) = 116.0564.

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 3.186 102.400 3.611
201612 3.212 102.600 3.633
201703 3.271 103.200 3.678
201706 3.253 103.100 3.662
201709 3.311 104.100 3.691
201712 3.361 104.500 3.733
201803 3.429 105.300 3.779
201806 3.369 104.900 3.727
201809 3.384 106.600 3.684
201812 3.468 106.500 3.779
201903 3.523 107.700 3.796
201906 3.397 107.700 3.661
201909 3.442 109.800 3.638
201912 3.558 111.200 3.713
202003 3.599 112.300 3.719
202006 3.523 110.400 3.704
202009 3.652 111.700 3.794
202012 3.842 111.500 3.999
202103 5.028 112.662 5.180
202106 5.052 111.769 5.246
202109 5.293 112.215 5.474
202112 5.510 113.108 5.654
202203 5.782 114.335 5.869
202206 5.943 114.558 6.021
202209 6.271 115.339 6.310
202212 6.453 115.116 6.506
202303 9.060 115.116 9.134
202306 9.012 114.558 9.130
202309 9.419 115.339 9.478
202312 9.487 114.781 9.592
202403 9.712 115.227 9.782
202406 9.429 114.781 9.534
202409 9.601 115.785 9.624
202412 9.680 114.893 9.778
202503 9.969 115.116 10.050
202506 9.957 114.907 10.057
202509 10.008 115.471 10.059
202512 9.970 115.832 9.989
202603 10.154 116.303 10.132
202606 10.263 116.056 10.263

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥ mean?
Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) has a Cyclically Adjusted Book per Share of ¥ as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors.
Is Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Zhejiang Jiuzhou Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥. Overall, Zhejiang Jiuzhou Pharmaceutical Co has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥ can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors. Zhejiang Jiuzhou Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Jiuzhou Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.84, compared to a current price of ¥15.52 — trading 7.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥. Zhejiang Jiuzhou Pharmaceutical Co's overall GF Score™ is 98/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456), the current Cyclically Adjusted Book per Share is ¥ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥15.52 is trading 7.8% below its estimated GF Value™ of ¥16.84. GuruFocus considers Zhejiang Jiuzhou Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:603456:

  • Cyclically Adjusted Book per Share: ¥
  • GF Value™: ¥16.84 vs. price of ¥15.52 (7.8% below fair value)
  • GF Score™: 98/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603456 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Jiuzhou Pharmaceutical Co Business Description

Address No. 99 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, and Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
98GF Score

Get the complete analysis for SHSE:603456

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.52
Price
¥16.84
GF Value